Second Covid-19 trial paused within 24 hours over safety concerns
Eli Lilly suspended its Phase 3 trial of its lab-produced antibody treatment in hospitalised patients over an unspecified incident.
Full Article
Second Covid-19 trial paused within 24 hours over safety concerns
Khaleej Times
0 shares
1 views
You might like
Related news coverage
NA Proactive news snapshot: Medexus Pharmaceuticals, Next Green Wave, Humanigen, Canada Silver Cobalt Works, American Resources UPDATE...
Proactive Investors
Medexus Pharmaceuticals Inc (CVE:MDP) (OTCQX:MEDXF) revealed that it has struck an agreement with Geneva, Switzerland-based..
-
NA Proactive news snapshot: American Resources, MagicMed Industries, AIM ImmunoTech, Water Tower Research, Genprex UPDATE ...
Proactive Investors
-
NA Proactive news snapshot: Algernon Pharmaceuticals, Loop Insights, Esports Entertainment, BioSig Technologies …
Proactive Investors
-
Second wave will be 'weeks and months' of limiting contacts, but Trudeau says 'blunt' lockdowns unnecessary
National Post
-
O'Toole slams outsourcing to China, calls for better conditions for workers
National Post
Advertisement
More coverage
Group calls for end to 'cozy' and 'unacceptable' relationship between senior government officials and Facebook
National Post
OTTAWA – A broadcasting advocacy group is urging the federal Heritage minister to put an end to the seemingly “cozy” and..
-
Volvo S60 2020 long-term review
Autocar
-
NA Proactive news snapshot: Revive Therapeutics, KULR Technology, Lexaria Bioscience, TRACON Pharmaceuticals UPDATE …
Proactive Investors
-
NA Proactive news snapshot: KWESST Micro Systems, WeedMD, Bragg Gaming Group, MGX Minerals, Phunware, Nextleaf Solutions, Candelaria Mining UPDATE…
Proactive Investors
-
Nissan Juke 2020 long-term review
Autocar